Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.84
-0.025-1.34%
Last update: Dec 12, 1:23 PM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Nkarta (NKTX) stock?
You can purchase shares of Nkarta (NASDAQ:NKTX) through any online brokerage.
Who are Nkarta (NKTX) competitors?
Other companies in Nkarta’s space includes: Connect Biopharma Holdings Ltd (NASDAQ:CNTB), Atossa Therapeutics Inc (NASDAQ:ATOS), Elicio Therapeutics Inc (NASDAQ:ELTX), Inovio Pharmaceuticals Inc (NASDAQ:INO) and Fate Therapeutics Inc (NASDAQ:FATE).
What is the forecast, or price target, for Nkarta (NKTX) stock?
Nkarta has a consensus price target of $13.86.
What is the current price for Nkarta (NKTX)?
The stock price for Nkarta (NASDAQ: NKTX) is $1.845 last updated December 12, 2025 at 1:23 PM EST.
Does Nkarta (NKTX) pay a dividend?
There are no upcoming dividends for Nkarta.
When is Nkarta (NASDAQ:NKTX) reporting earnings?
Nkarta does not have any upcoming earnings scheduled.
Is Nkarta (NKTX) going to split?
There is no upcoming split for Nkarta.
What sector and industry does Nkarta (NKTX) operate in?
Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
